Financial Gravity Asset Management’s Core Laboratories CLB Stock Holding History

Financial Gravity Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$28K	Sell	218 -9	-4%	-$274	0.01%	719
2021 Q2	$39K	Buy	+227	New	+$8.14K	0.01%	646
2019 Q4	$38K	Sell	2 -673	-100%	-$30.2K	0.03%	764
2019 Q3	$31K	Sell	675 -238	-26%	-$11.1K	0.03%	372
2019 Q2	$48K	Sell	913 -181	-17%	-$10.6K	0.04%	324
2019 Q1	$75K	Buy	+1,094	New	+$73.3K	0.06%	241
2018 Q3	$69K	Buy	824 +80	+11%	+$9.03K	0.07%	262
2018 Q2	$84K	Buy	744 +181	+32%	+$22K	0.08%	237
2018 Q1	$68K	Buy	+563	New	+$62.3K	0.07%	245

Other funds holding CLB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Financial Gravity Asset Management's CLB Position: Q3 2021 in Review

Financial Gravity Asset Management reduced its Core Laboratories (CLB) stake by 4% in Q3 2021, selling an estimated $274 and leaving 218 shares worth $28K. The position accounts for 0.01% of the portfolio, ranked #719.

Financial Gravity Asset Management first reported a position in CLB in Q1 2018 and has held it in 9 quarters since. The position peaked at $84K in Q2 2018. 198 funds tracked by Wall St. Rank hold CLB as of Q3 2021.

Financial Gravity Asset Management held 218 shares of Core Laboratories worth $28K as of Q3 2021.
Financial Gravity Asset Management sold 9 Core Laboratories shares in Q3 2021, an estimated $274.
Core Laboratories made up 0.01% of Financial Gravity Asset Management's portfolio in Q3 2021, its #719 holding.
Financial Gravity Asset Management first reported a position in Core Laboratories in Q1 2018 and has held it in 9 quarters since.
Financial Gravity Asset Management's Core Laboratories position peaked at $84K in Q2 2018.
198 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2021.

Based on Financial Gravity Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.